SPERATUM
Speratum is a biopharmaceutical company focused on microRNA-directed oncology therapies. The Company was founded in 2014 by Christian Marín-Müller, Ph.D. and is dedicated to the development of a patented treatment for pancreatic cancer based on the combination of tumor suppressive microRNA molecules and nanoparticle-based drug delivery technologies. The Company is currently entering the final stage of preclinical trials for the pancreatic cancer therapy, while simultaneously expanding the patent’s coverage to incorporate other types of cancer and non-cancer indications and illnesses and expanding its intellectual property (IP) portfolio with complementary technologies in the fields of nanotechnology, medical devices and veterinary medicine.
SPERATUM
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-03-01
Address:
San José, San Jose, Costa Rica
Country:
Costa Rica
Website Url:
http://www.speratum.com
Total Employee:
11+
Status:
Active
Contact:
+506-4032-1880
Email Addresses:
[email protected]
Total Funding:
2.8 M USD
Technology used in webpage:
Amazon Google Apps For Business GoDaddy DNS GStatic Google Static Content AWS Global Accelerator
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Current Advisors List
Current Employees Featured
Founder
Investors List
Carao Ventures
Carao Ventures investment in Convertible Note - Speratum
Carao Ventures
Carao Ventures investment in Seed Round - Speratum
Official Site Inspections
http://www.speratum.com
- Host name: 104.21.38.113
- IP address: 104.21.38.113
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
